Re: Muayad et al.: Comparative effects of glucagon-like peptide 1 receptor agonists and metformin on glaucoma risk in patients with type 2 diabetes (Ophthalmology. 2025;132:271-279)
Ophthalmology. 2025 Apr;132(4):e61.
doi: 10.1016/j.ophtha.2024.11.018.
Epub 2024 Dec 24.
1 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Optometry, Shu-Zen Junior Colleage of Medicine and Management, Kaohsing, Taiwan.
3 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. Electronic address: jccwei@gmail.com.